Skip to main content

Table 1 Patient numbers 1–8 were COVID-19 positive

From: Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID-19): possible role for the NLRP3 inflammasome

Patient

Gender

Age

Race

Known medical history

Substance abuse (smoking/alcohol)

1

Female

61

W

Asthma and stroke

Non- smoking

2

Female

63

W

Breast cancer and therapy related acute leukemia

Smoking

3

Female

73

W

COPD

Smoking and Alcohol

4

Female

94

W

COPD, Coronary Artery Disease and Siogrens disease

Not known

5

Male

50

B

Myeloproliferative disorder and Pulmonary/portal hypertension

Not known

6

Male

72

B

Dementia, diabetes and hypertension

Not known

7

Male

74

B

Pulmonary Embolsim and deep vein thrombosis and hypertension

Not known

8

Male

85

U

Cerebral Vascular disease

Not known

9

Male

63

W

Heart Transplant

Not known

10.*

Female

59

B

Emphysema

Not known

11.*

Male

81

B

Emphysema

Not known

12.*

Male

40

B

Bronchopneumonia

Not known

13.*

Female

62

W

Diffuse alveolar damage; chronic lung disease

Not known

14.*

Male

72

B

End stage lung disease

Not known

15.*

Female

68

W

Diffuse alveolar damage; COPD and renal cell carcinoma

Not known

16

Female

69

B

Breast Cancer, Mild edema in lung

Not known

17.*

Male

77

U

Diffuse alveolar damage and COPD

Not known

18.*

Male

73

B

Aspiration pneumonia; diabetes

Not known

19

Male

57

W

Sarcoid

Not known

  1. Patient numbers 9–19 were non-COVID-19. Of these * denote non COVID-19 ARDS. The rest were (Patient numbers 9, 16, 19) were non-COVID-19 non-ARDS. B, W and U denote black, white and unknown respectively